Dimazon Vet.

Primær information

  • Handelsnavn:
  • Dimazon Vet. 50 mg/ml injektionsvæske, opløsning
  • Dosering:
  • 50 mg/ml
  • Lægemiddelform:
  • injektionsvæske, opløsning
  • Brugt til:
  • Dyr
  • Medicin typen:
  • Allopatiske stof

Dokumenter

  • for den brede offentlighed:
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.


    Anmode informationsbrochure for offentligheden.

Lokation

  • Fås i:
  • Dimazon Vet. 50 mg/ml injektionsvæske, opløsning
    Danmark
  • Sprog:
  • dansk

Terapeutisk information

  • Terapeutisk gruppe:
  • Hest, Hund, Kvæg

Andre oplysninger

Status

  • Kilde:
  • Lægemiddelstyrelsen - Danish Medicines Agency
  • Autorisationsnummer:
  • 05907
  • Sidste ændring:
  • 23-02-2018

Produktresumé

20. november 2017

PRODUKTRESUMÉ

for

Dimazon Vet., injektionsvæske, opløsning

0.

D.SP.NR

20766

1.

VETERINÆRLÆGEMIDLETS NAVN

Dimazon Vet.

2.

KVALITATIV OG KVANTITATIV SAMMENSÆTNING

Aktivt stof:

Furosemid 50 mg/ml

Hjælpestof:

Benzylalkohol 15 mg/ml

Alle hjælpestoffer er anført under pkt. 6.1

3.

LÆGEMIDDELFORM

Injektionsvæske, opløsning.

4.

KLINISKE OPLYSNINGER

4.1

Dyrearter

Hund. Kvæg. Hest.

4.2

Terapeutiske indikationer

Vandretentioner, saltretentioner, ødemer.

4.3

Kontraindikationer

Truende eller manifest leverinsufficiens.

4.4

Særlige advarsler

Ingen.

4.5

Særlige forsigtighedsregler vedrørende brugen

Særlige forsigtighedsregler for dyret

Ingen.

05907_spc.doc

Side 1 af 4

Særlige forsigtighedsregler for personer, der administrerer lægemidlet

Ingen.

Andre forsigtighedsregler

4.6

Bivirkninger

Ved høje doser kan elektrolytmangel (kalium, natrium, kalcium) samt hypovolæmi udvikles.

På grund af den diuretiske virkning kan der forekomme hæmokoncentration og reduceret

kredsløbsfunktion. I tilfælde af længerevarende behandling kan der forekomme hypokaliæmi

og hyponatriæmi.

Forbigående ototoksicitet kan forekomme hos hunde og katte i meget sjældne tilfælde.

4.7

Drægtighed, diegivning eller æglægning

Kan anvendes.

4.8

Interaktion med andre lægemidler og andre former for interaktion

Ved kronisk dosering kan hypokaliæmi øge risikoen for toksiske bivirkninger af digitalis.

4.9

Dosering og indgivelsesmåde

Hund:

1 ml/10 kg kropsvægt, 1-2 gange dagligt

Hest:

5-10 ml, 1-2 gange dagligt

Kvæg:

5-10 ml, 1-2 gange dagligt

Til i.v. og i.m. injektion.

Kaliumrig diæt samt lav initial dosis anbefales ved påtænkt langvarig dosering.

4.10

Overdosering

Hypovolæmi og dehydrering associeret med forstyrrelser i elektrolytbalancen kan

forekomme.

4.11

Tilbageholdelsestid

Slagtning: i.m. og i.v.: 0 dage

Mælk: i.m. og i.v.: 1 dag

5.

FARMAKOLOGISKE EGENSKABER

Farmakoterapeutisk gruppe: Diuretica; sulfonamider, usammensatte

ATCvet-kode: QC 03 CA 01

5.1

Farmakodynamiske egenskaber

Dimazon Vet. indeholder furosemid, et "loop-diureticum", som virker gennem hæmning af

Cl-Na-K reabsorbtionen i det opadstigende ben af Henles slynge samt i de proksimale

tubuli. Den resulterende højere NaCl-koncentration binder vand i præurinen. Effekten af

Dimazon Vet. er stærkt dosisafhængig. Kalium-, chlorid-, natrium-, magnesium- og

kalciumudskillelsen øges.

5.2

Farmakokinetiske egenskaber

05907_spc.doc

Side 2 af 4

Efter i.v. administration indtræder virkningen umiddelbart. Terapeutisk effekt varer i 5-6

timer.

5.3

Miljømæssige forhold

6.

FARMACEUTISKE OPLYSNINGER

6.1

Hjælpestoffer

Benzylalkohol

Monoethanolamin

Dinatriumedetatdihydrat

Natriumklorid

Natriumsulfit, vandfrit

Vand til injektionsvæske

6.2

Uforligeligheder

Ingen kendte.

6.3

Opbevaringstid

I salgspakning: 3 år.

Efter første åbning af den indre emballage: 28 dage.

6.4

Særlige opbevaringsforhold

Må ikke opbevares ved temperaturer over 25°C.

Opbevares i den ydre karton for at beskytte mod lys.

6.5

Emballage

10 ml hætteglas af klart glas med gummilukke, aluminiumskappe og plastforsegling.

6.6

Særlige forholdsregler ved bortskaffelse af rester af lægemidlet eller affald

Ikke anvendte veterinærlægemidler samt affald heraf bør destrueres i henhold til lokale

retningslinjer.

7.

INDEHAVER AF MARKEDSFØRINGSTILLADELSEN

Intervet International B.V.

Wim de Körverstraat 35

5831 AN Boxmeer

Holland

Repræsentant

MSD Animal Health A/S

Havneholmen 25

1561 København V

8.

MARKEDSFØRINGSTILLADELSESNUMMER (NUMRE)

5907

05907_spc.doc

Side 3 af 4

9.

DATO FOR FØRSTE MARKEDSFØRINGSTILLADELSE

15. september 1972

10.

DATO FOR ÆNDRING AF TEKSTEN

20. november 2017

11.

UDLEVERINGSBESTEMMELSE

05907_spc.doc

Side 4 af 4

  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.

    Anmode informationsbrochure for offentligheden.



  • Dokumenter på andre sprog er tilgængelige her

11-1-2018

Is My Dog or Cat a Healthy Weight? Important Questions to Ask the Vet

Is My Dog or Cat a Healthy Weight? Important Questions to Ask the Vet

Just as obesity has become a serious problem in people, it's also a growing problem in pets, one that can seriously harm your pet's health.

FDA - U.S. Food and Drug Administration

15-6-2017



Out-of-Stock – GastroGard ad us. vet., orale Paste

Out-of-Stock – GastroGard ad us. vet., orale Paste

Befristetes Inverkehrbringen in ausländischer Aufmachung.

Swissmedic - Swiss Agency for Therapeutic Products

23-4-2018

UTERCLEANSE (Urea) Tablet [MWI/Vet One]

UTERCLEANSE (Urea) Tablet [MWI/Vet One]

Updated Date: Apr 23, 2018 EST

US - DailyMed

23-4-2018

VITAMIN B12 (Cyanocobalamin) Injection, Solution [MWI/Vet One]

VITAMIN B12 (Cyanocobalamin) Injection, Solution [MWI/Vet One]

Updated Date: Apr 23, 2018 EST

US - DailyMed

11-4-2018

FUROSEMIDE (Furosemide) Tablet [REMEDYREPACK INC.]

FUROSEMIDE (Furosemide) Tablet [REMEDYREPACK INC.]

Updated Date: Apr 11, 2018 EST

US - DailyMed

9-4-2018

FUROSEMIDE Injection, Solution [Medical Purchasing Solutions, LLC]

FUROSEMIDE Injection, Solution [Medical Purchasing Solutions, LLC]

Updated Date: Apr 9, 2018 EST

US - DailyMed

2-4-2018

FUROSEMIDE (Furosemide) Tablet [A-S Medication Solutions]

FUROSEMIDE (Furosemide) Tablet [A-S Medication Solutions]

Updated Date: Apr 2, 2018 EST

US - DailyMed

22-3-2018

LASIX (Furosemide) Tablet [Valeant Pharmaceuticals International Inc.]

LASIX (Furosemide) Tablet [Valeant Pharmaceuticals International Inc.]

Updated Date: Mar 22, 2018 EST

US - DailyMed

22-3-2018

LASIX (Furosemide) Tablet [Validus Pharmaceuticals LLC]

LASIX (Furosemide) Tablet [Validus Pharmaceuticals LLC]

Updated Date: Mar 22, 2018 EST

US - DailyMed

22-3-2018

FUROSEMIDE Tablet [RedPharm Drug, Inc.]

FUROSEMIDE Tablet [RedPharm Drug, Inc.]

Updated Date: Mar 22, 2018 EST

US - DailyMed

19-3-2018

FUROSEMIDE Tablet [QPharma Inc]

FUROSEMIDE Tablet [QPharma Inc]

Updated Date: Mar 19, 2018 EST

US - DailyMed

9-3-2018

FUROSEMIDE Solution [Morton Grove Pharmaceuticals, Inc.]

FUROSEMIDE Solution [Morton Grove Pharmaceuticals, Inc.]

Updated Date: Mar 9, 2018 EST

US - DailyMed

7-3-2018

VITAMIN B12 (Cyanocobalamin) Injection [Vet Tek]

VITAMIN B12 (Cyanocobalamin) Injection [Vet Tek]

Updated Date: Mar 7, 2018 EST

US - DailyMed

7-3-2018

VITAMIN C (Sodium Ascorbate) Injection [Vet Tek]

VITAMIN C (Sodium Ascorbate) Injection [Vet Tek]

Updated Date: Mar 7, 2018 EST

US - DailyMed

23-2-2018

FUROSEMIDE Tablet [Preferred Pharmaceuticals, Inc.]

FUROSEMIDE Tablet [Preferred Pharmaceuticals, Inc.]

Updated Date: Feb 23, 2018 EST

US - DailyMed

7-2-2018

FUROSEMIDE Tablet [A-S Medication Solutions]

FUROSEMIDE Tablet [A-S Medication Solutions]

Updated Date: Feb 7, 2018 EST

US - DailyMed

2-2-2018

Meloxoral (Le Vet B.V.)

Meloxoral (Le Vet B.V.)

Meloxoral (Active substance: Meloxicam) - Centralised - Yearly update - Commission Decision (2018)657 of Fri, 02 Feb 2018

Europe -DG Health and Food Safety

31-1-2018

Lasix vs. Aldactone

Lasix vs. Aldactone

Lasix (furosemide) and Aldactone (spironolactone) are used to reduce edema (fluid accumulation) caused by heart, liver or kidney problems, or high blood pressure (hypertension). Lasix may also be used with antihypertensive drugs to control high blood pressure hypertension). Aldactone is also used to reduce edema caused by certain patients with hyperaldosteronism. Lasix and Aldactone belong to different drug classes. Lasix is an anthranilic acid derivative used as a strong loop diuretic and Aldactone is ...

US - RxList

31-1-2018

Lasix vs. Bumex

Lasix vs. Bumex

Lasix (furosemide) and Bumex (bumetanide) are loop diuretics (water pills) used to treat excessive fluid accumulation (edema) caused by congestive heart failure, liver failure, renal failure, and nephritic syndrome. Lasix and Bumex may be used with antihypertensive drugs to control high blood pressure (hypertension).

US - RxList

31-1-2018

Lasix vs. Thiazides

Lasix vs. Thiazides

Lasix (furosemide) and thiazides are types of diuretics (water pills) used to treat excessive fluid accumulation (edema) caused by congestive heart failure, liver failure, renal failure, and nephritic syndrome. They may also be used with antihypertensive drugs to control high blood pressure (hypertension).

US - RxList

19-1-2018

DIASCREEN 12-PANEL MEDICATED COLLECTION SYSTEM (Furosemide) Kit [IT3 Medical LLC]

DIASCREEN 12-PANEL MEDICATED COLLECTION SYSTEM (Furosemide) Kit [IT3 Medical LLC]

Updated Date: Jan 19, 2018 EST

US - DailyMed

19-1-2018

FUROSEMIDE Tablet [IT3 Medical LLC]

FUROSEMIDE Tablet [IT3 Medical LLC]

Updated Date: Jan 19, 2018 EST

US - DailyMed

12-1-2018

FUROSEMIDE Injection, Solution [REMEDYREPACK INC.]

FUROSEMIDE Injection, Solution [REMEDYREPACK INC.]

Updated Date: Jan 12, 2018 EST

US - DailyMed

10-1-2018

FUROSEMIDE (Furosemide) Tablet [RPK Pharmaceuticals, Inc.]

FUROSEMIDE (Furosemide) Tablet [RPK Pharmaceuticals, Inc.]

Updated Date: Jan 10, 2018 EST

US - DailyMed

8-1-2018

DEXAMETHASONE Injection, Solution [MWI (Vet One)]

DEXAMETHASONE Injection, Solution [MWI (Vet One)]

Updated Date: Jan 8, 2018 EST

US - DailyMed

2-1-2018

FUROSEMIDE (Furosemide) Tablet [St. Mary'S Medical Park Pharmacy]

FUROSEMIDE (Furosemide) Tablet [St. Mary'S Medical Park Pharmacy]

Updated Date: Jan 2, 2018 EST

US - DailyMed

2-1-2018

FUROSEMIDE (Furosemide) Tablet [Bryant Ranch Prepack]

FUROSEMIDE (Furosemide) Tablet [Bryant Ranch Prepack]

Updated Date: Jan 2, 2018 EST

US - DailyMed

29-12-2017

FUROSEMIDE Tablet [Mylan Institutional Inc.]

FUROSEMIDE Tablet [Mylan Institutional Inc.]

Updated Date: Dec 29, 2017 EST

US - DailyMed

26-12-2017

FUROSEMIDE Injection [Wockhardt USA LLC.]

FUROSEMIDE Injection [Wockhardt USA LLC.]

Updated Date: Dec 26, 2017 EST

US - DailyMed

21-12-2017

SALIX (Furosemide) Injection [Merck Sharp Dohme Corp.]

SALIX (Furosemide) Injection [Merck Sharp Dohme Corp.]

Updated Date: Dec 21, 2017 EST

US - DailyMed

20-12-2017

Sedadex (Le Vet Beheer B.V.)

Sedadex (Le Vet Beheer B.V.)

Sedadex (Active substance: dexmedetomidine) - Centralised - Yearly update - Commission Decision (2017)9005 of Wed, 20 Dec 2017

Europe -DG Health and Food Safety

18-12-2017

FUROTABS (Furosemide) Tablet [Henry Schein Animal Health]

FUROTABS (Furosemide) Tablet [Henry Schein Animal Health]

Updated Date: Dec 18, 2017 EST

US - DailyMed

18-12-2017

FUROJECT (Furosemide) Injection [Henry Schein Animal Health]

FUROJECT (Furosemide) Injection [Henry Schein Animal Health]

Updated Date: Dec 18, 2017 EST

US - DailyMed

12-12-2017

Regulatory and procedural guideline:  Quality review of documents (QRD) guidance on the use of approved pictograms on the packaging of veterinary medicinal products authorised via the centralised (CP), mutual recognition (MRP) and decentralised procedures

Regulatory and procedural guideline: Quality review of documents (QRD) guidance on the use of approved pictograms on the packaging of veterinary medicinal products authorised via the centralised (CP), mutual recognition (MRP) and decentralised procedures

The need for a harmonised, approved ‘catalogue’ of pictograms was identified and this draft guidance was developed as a collaboration between the QRD (vet) group, the CMDv, CVMP and industry stakeholders. The use of pictograms from Annex 1 of this guidance will apply to the national authorisation procedures, including MRP and DCP and to the centralised procedure (EMA). The aim of the guidance is to outline the approval requirements and processes where pictograms from Annex 1 are used on the product liter...

Europe - EMA - European Medicines Agency

12-12-2017

XYLAMED (Xylazine) Injection, Solution [MWI/Vet One]

XYLAMED (Xylazine) Injection, Solution [MWI/Vet One]

Updated Date: Dec 12, 2017 EST

US - DailyMed

8-12-2017

FUROSEMIDE Tablet [St Marys Medical Park Pharmacy]

FUROSEMIDE Tablet [St Marys Medical Park Pharmacy]

Updated Date: Dec 8, 2017 EST

US - DailyMed

15-11-2017

DISAL (Furosemide) Tablet [Boehringer Ingelheim Vetmedica, Inc.]

DISAL (Furosemide) Tablet [Boehringer Ingelheim Vetmedica, Inc.]

Updated Date: Nov 15, 2017 EST

US - DailyMed

8-11-2017

TETRACYCLINE HYDROCHLORIDE (Tc Vet 324) Powder [VetOne]

TETRACYCLINE HYDROCHLORIDE (Tc Vet 324) Powder [VetOne]

Updated Date: Nov 8, 2017 EST

US - DailyMed

26-10-2017

FUROSEMIDE (Furosemide) Tablet [Aphena Pharma Solutions - Tennessee, LLC]

FUROSEMIDE (Furosemide) Tablet [Aphena Pharma Solutions - Tennessee, LLC]

Updated Date: Oct 26, 2017 EST

US - DailyMed

10-10-2017

Equisolon (Le Vet B.V.)

Equisolon (Le Vet B.V.)

Equisolon (Active substance: Prednisolone) - Centralised - Yearly update - Commission Decision (2017)6866 of Tue, 10 Oct 2017

Europe -DG Health and Food Safety

3-10-2017

FUROSEMIDE Tablet [Contract Pharmacy Services-PA]

FUROSEMIDE Tablet [Contract Pharmacy Services-PA]

Updated Date: Oct 3, 2017 EST

US - DailyMed

27-9-2017

FUROSEMIDE Tablet [Solco Healthcare LLC]

FUROSEMIDE Tablet [Solco Healthcare LLC]

Updated Date: Sep 27, 2017 EST

US - DailyMed

26-9-2017

FUROSEMIDE Tablet [REMEDYREPACK INC.]

FUROSEMIDE Tablet [REMEDYREPACK INC.]

Updated Date: Sep 26, 2017 EST

US - DailyMed

25-9-2017

FUROSEMIDE Tablet [Mas Management Group, Inc.]

FUROSEMIDE Tablet [Mas Management Group, Inc.]

Updated Date: Sep 25, 2017 EST

US - DailyMed

21-9-2017

VET LUBE (Propylene Glycol) Gel [Clipper Distributing Company]

VET LUBE (Propylene Glycol) Gel [Clipper Distributing Company]

Updated Date: Sep 21, 2017 EST

US - DailyMed

6-9-2017

LASIX (Furosemide) Tablet [Preferred Pharmaceuticals Inc.]

LASIX (Furosemide) Tablet [Preferred Pharmaceuticals Inc.]

Updated Date: Sep 6, 2017 EST

US - DailyMed

5-9-2017

FUROSEMIDE Tablet [Preferred Pharmaceuticals Inc.]

FUROSEMIDE Tablet [Preferred Pharmaceuticals Inc.]

Updated Date: Sep 5, 2017 EST

US - DailyMed

1-9-2017

FUROSEMIDE (Furosemide) Tablet [PD-Rx Pharmaceuticals, Inc.]

FUROSEMIDE (Furosemide) Tablet [PD-Rx Pharmaceuticals, Inc.]

Updated Date: Sep 1, 2017 EST

US - DailyMed

22-8-2017

FUROSEMIDE Injection, Solution [General Injectables Vaccines, Inc]

FUROSEMIDE Injection, Solution [General Injectables Vaccines, Inc]

Updated Date: Aug 22, 2017 EST

US - DailyMed

10-8-2017

NEXGARD (Afoxolaner) Tablet, Chewable [Frontline Vet Labs]

NEXGARD (Afoxolaner) Tablet, Chewable [Frontline Vet Labs]

Updated Date: Aug 10, 2017 EST

US - DailyMed

28-7-2017

TC VET 324 (Tetracycline Hydrochloride) Powder, For Solution [MWI]

TC VET 324 (Tetracycline Hydrochloride) Powder, For Solution [MWI]

Updated Date: Jul 28, 2017 EST

US - DailyMed

27-7-2017

FUROSEMIDE Tablet [NuCare Pharmaceuticals,Inc.]

FUROSEMIDE Tablet [NuCare Pharmaceuticals,Inc.]

Updated Date: Jul 27, 2017 EST

US - DailyMed

26-7-2017

FUROSEMIDE Tablet FUROSEMIDE Solution [West-Ward Pharmaceuticals Corp.]

FUROSEMIDE Tablet FUROSEMIDE Solution [West-Ward Pharmaceuticals Corp.]

Updated Date: Jul 26, 2017 EST

US - DailyMed

21-7-2017

FUROSEMIDE Tablet [Aphena Pharma Solutions - Tennessee, LLC]

FUROSEMIDE Tablet [Aphena Pharma Solutions - Tennessee, LLC]

Updated Date: Jul 21, 2017 EST

US - DailyMed

21-6-2017

Prevomax (Le Vet Beheer B.V.)

Prevomax (Le Vet Beheer B.V.)

Prevomax (Active substance: maropitant) - Centralised - Authorisation - Commission Decision (2017)4338 of Wed, 21 Jun 2017 European Medicines Agency (EMA) procedure number: EMEA/V/C/4331

Europe -DG Health and Food Safety

15-6-2017

FUROSEMIDE Injection, Solution [Claris Lifesciences Inc.]

FUROSEMIDE Injection, Solution [Claris Lifesciences Inc.]

Updated Date: Jun 15, 2017 EST

US - DailyMed